drugset / Trial / NCT01537354

Comparison in Pulmonary Compliance Between Curosurf and Survanta in Preterm Infants With Respiratory Distress Syndrome

NCT01537354

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a null hypothesis study. The investigators hypothesize that there will be no difference in changes in dynamic compliance when measured at 15, 30, 45 and 60 minute intervals after administration of either surfactant and there will be no differences in the number of doses needed between the two surfactants in premature infants admitted to our NICU.

Timeline

Start
2012-06
Primary completion
2013-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Beractant Other / unclassified 100 mg/kg Other
Comparator Poractant alfa Other / unclassified 100 mg/kg Other